Skip to content
Screener

AngioDynamics ANGO Price / earnings

Price / earnings at other companies

Abbott logo
AbbottABT
29.1×+11.9×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
44.3×+13.3×
TFX
TeleflexTFX
27.7×-9.9×
Stryker logo
StrykerSYK
32.4×-18.2×
Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
Boston Scientific logo
Boston ScientificBSX
17.3×-44.4×

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M—
CapEx$413.0K-46.8%
Free cash flow$17.0M—

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S2×+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%—

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from AngioDynamics’s reported figures.

market cap/net income=49.4×

Based on the most recent quarter.

The source filing: AngioDynamics’s 10-Q, filed October 5, 2023. Open the filing →

Filed
Oct 5, 2023
Fiscal quarter
Q1 FY2024
Calendar quarter
Q3 2023
Accession
0001628280-23-033979

FAQ

What is AngioDynamics's price / earnings?
AngioDynamics (ANGO) reported price / earnings of 49.4× in Q2 2023.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about AngioDynamics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude